The global market for Orally Disintegrating Tablets was valued at US$ 17420 million in the year 2024 and is projected to reach a revised size of US$ 37390 million by 2031, growing at a CAGR of 11.7% during the forecast period.

Orally Disintegrating Tablets Market

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 40%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablets.

The Orally Disintegrating Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Orally Disintegrating Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Orally Disintegrating Tablets Market Report

Report Metric	Details
Report Name	Orally Disintegrating Tablets Market
Accounted market size in year	US$ 17420 million
Forecasted market size in 2031	US$ 37390 million
CAGR	11.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Anti-Psychotics Drug Anti-Epileptics Drug Other
Segment by Application	CNS Diseases Gastrointestinal Diseases CVS Diseases Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Orally Disintegrating Tablets Market growing?

Ans: The Orally Disintegrating Tablets Market witnessing a CAGR of 11.7% during the forecast period 2025-2031.

What is the Orally Disintegrating Tablets Market size in 2031?

Ans: The Orally Disintegrating Tablets Market size in 2031 will be US$ 37390 million.

What is the Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol Myers Squibb, Conquer share in Orally Disintegrating Tablets Market?

Ans: Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market.

What is the Orally Disintegrating Tablets Market share by region?

Ans: North America is the largest market of glass packaging, holding a share more than 40%.

What is the Orally Disintegrating Tablets Market share by application?

Ans: The most common application is in CNS diseases packaging, with a share about 55%.

Who are the main players in the Orally Disintegrating Tablets Market report?

Ans: The main players in the Orally Disintegrating Tablets Market are Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer

What are the Application segmentation covered in the Orally Disintegrating Tablets Market report?

Ans: The Applications covered in the Orally Disintegrating Tablets Market report are CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other

What are the Type segmentation covered in the Orally Disintegrating Tablets Market report?

Ans: The Types covered in the Orally Disintegrating Tablets Market report are Anti-Psychotics Drug, Anti-Epileptics Drug, Other

1 Orally Disintegrating Tablets Market Overview

1.1 Product Definition

1.2 Orally Disintegrating Tablets by Type

1.2.1 Global Orally Disintegrating Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 Anti-Psychotics Drug

1.2.3 Anti-Epileptics Drug

1.2.4 Other

1.3 Orally Disintegrating Tablets by Application

1.3.1 Global Orally Disintegrating Tablets Market Value by Application (2024 VS 2031)

1.3.2 CNS Diseases

1.3.3 Gastrointestinal Diseases

1.3.4 CVS Diseases

1.3.5 Other

1.4 Global Orally Disintegrating Tablets Market Size Estimates and Forecasts

1.4.1 Global Orally Disintegrating Tablets Revenue 2020-2031

1.4.2 Global Orally Disintegrating Tablets Sales 2020-2031

1.4.3 Global Orally Disintegrating Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Orally Disintegrating Tablets Market Competition by Manufacturers

2.1 Global Orally Disintegrating Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Orally Disintegrating Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Orally Disintegrating Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Orally Disintegrating Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Orally Disintegrating Tablets, Product Type & Application

2.7 Global Key Manufacturers of Orally Disintegrating Tablets, Date of Enter into This Industry

2.8 Global Orally Disintegrating Tablets Market Competitive Situation and Trends

2.8.1 Global Orally Disintegrating Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Orally Disintegrating Tablets Players Market Share by Revenue

2.8.3 Global Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Orally Disintegrating Tablets Market Scenario by Region

3.1 Global Orally Disintegrating Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Orally Disintegrating Tablets Sales by Region: 2020-2031

3.2.1 Global Orally Disintegrating Tablets Sales by Region: 2020-2025

3.2.2 Global Orally Disintegrating Tablets Sales by Region: 2026-2031

3.3 Global Orally Disintegrating Tablets Revenue by Region: 2020-2031

3.3.1 Global Orally Disintegrating Tablets Revenue by Region: 2020-2025

3.3.2 Global Orally Disintegrating Tablets Revenue by Region: 2026-2031

3.4 North America Orally Disintegrating Tablets Market Facts & Figures by Country

3.4.1 North America Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Orally Disintegrating Tablets Sales by Country (2020-2031)

3.4.3 North America Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Orally Disintegrating Tablets Market Facts & Figures by Country

3.5.1 Europe Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Orally Disintegrating Tablets Sales by Country (2020-2031)

3.5.3 Europe Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Orally Disintegrating Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Orally Disintegrating Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Orally Disintegrating Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Orally Disintegrating Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Orally Disintegrating Tablets Market Facts & Figures by Country

3.7.1 Latin America Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Orally Disintegrating Tablets Sales by Country (2020-2031)

3.7.3 Latin America Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Orally Disintegrating Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Orally Disintegrating Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Orally Disintegrating Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Orally Disintegrating Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Orally Disintegrating Tablets Sales by Type (2020-2031)

4.1.1 Global Orally Disintegrating Tablets Sales by Type (2020-2025)

4.1.2 Global Orally Disintegrating Tablets Sales by Type (2026-2031)

4.1.3 Global Orally Disintegrating Tablets Sales Market Share by Type (2020-2031)

4.2 Global Orally Disintegrating Tablets Revenue by Type (2020-2031)

4.2.1 Global Orally Disintegrating Tablets Revenue by Type (2020-2025)

4.2.2 Global Orally Disintegrating Tablets Revenue by Type (2026-2031)

4.2.3 Global Orally Disintegrating Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Orally Disintegrating Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Orally Disintegrating Tablets Sales by Application (2020-2031)

5.1.1 Global Orally Disintegrating Tablets Sales by Application (2020-2025)

5.1.2 Global Orally Disintegrating Tablets Sales by Application (2026-2031)

5.1.3 Global Orally Disintegrating Tablets Sales Market Share by Application (2020-2031)

5.2 Global Orally Disintegrating Tablets Revenue by Application (2020-2031)

5.2.1 Global Orally Disintegrating Tablets Revenue by Application (2020-2025)

5.2.2 Global Orally Disintegrating Tablets Revenue by Application (2026-2031)

5.2.3 Global Orally Disintegrating Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Orally Disintegrating Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Teva

6.1.1 Teva Company Information

6.1.2 Teva Description and Business Overview

6.1.3 Teva Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Teva Orally Disintegrating Tablets Product Portfolio

6.1.5 Teva Recent Developments/Updates

6.2 Merck

6.2.1 Merck Company Information

6.2.2 Merck Description and Business Overview

6.2.3 Merck Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Merck Orally Disintegrating Tablets Product Portfolio

6.2.5 Merck Recent Developments/Updates

6.3 Mylan

6.3.1 Mylan Company Information

6.3.2 Mylan Description and Business Overview

6.3.3 Mylan Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Mylan Orally Disintegrating Tablets Product Portfolio

6.3.5 Mylan Recent Developments/Updates

6.4 Pfizer

6.4.1 Pfizer Company Information

6.4.2 Pfizer Description and Business Overview

6.4.3 Pfizer Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Pfizer Orally Disintegrating Tablets Product Portfolio

6.4.5 Pfizer Recent Developments/Updates

6.5 Johnson and Johnson

6.5.1 Johnson and Johnson Company Information

6.5.2 Johnson and Johnson Description and Business Overview

6.5.3 Johnson and Johnson Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Johnson and Johnson Orally Disintegrating Tablets Product Portfolio

6.5.5 Johnson and Johnson Recent Developments/Updates

6.6 GSK

6.6.1 GSK Company Information

6.6.2 GSK Description and Business Overview

6.6.3 GSK Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GSK Orally Disintegrating Tablets Product Portfolio

6.6.5 GSK Recent Developments/Updates

6.7 Otsuka

6.7.1 Otsuka Company Information

6.7.2 Otsuka Description and Business Overview

6.7.3 Otsuka Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Otsuka Orally Disintegrating Tablets Product Portfolio

6.7.5 Otsuka Recent Developments/Updates

6.8 Eli Lilly and Company

6.8.1 Eli Lilly and Company Company Information

6.8.2 Eli Lilly and Company Description and Business Overview

6.8.3 Eli Lilly and Company Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Eli Lilly and Company Orally Disintegrating Tablets Product Portfolio

6.8.5 Eli Lilly and Company Recent Developments/Updates

6.9 AstraZeneca

6.9.1 AstraZeneca Company Information

6.9.2 AstraZeneca Description and Business Overview

6.9.3 AstraZeneca Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 AstraZeneca Orally Disintegrating Tablets Product Portfolio

6.9.5 AstraZeneca Recent Developments/Updates

6.10 Bristol-Myers Squibb

6.10.1 Bristol-Myers Squibb Company Information

6.10.2 Bristol-Myers Squibb Description and Business Overview

6.10.3 Bristol-Myers Squibb Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Bristol-Myers Squibb Orally Disintegrating Tablets Product Portfolio

6.10.5 Bristol-Myers Squibb Recent Developments/Updates

6.11 Conquer

6.11.1 Conquer Company Information

6.11.2 Conquer Description and Business Overview

6.11.3 Conquer Orally Disintegrating Tablets Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Conquer Orally Disintegrating Tablets Product Portfolio

6.11.5 Conquer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Orally Disintegrating Tablets Industry Chain Analysis

7.2 Orally Disintegrating Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Orally Disintegrating Tablets Production Mode & Process Analysis

7.4 Orally Disintegrating Tablets Sales and Marketing

7.4.1 Orally Disintegrating Tablets Sales Channels

7.4.2 Orally Disintegrating Tablets Distributors

7.5 Orally Disintegrating Tablets Customer Analysis

8 Orally Disintegrating Tablets Market Dynamics

8.1 Orally Disintegrating Tablets Industry Trends

8.2 Orally Disintegrating Tablets Market Drivers

8.3 Orally Disintegrating Tablets Market Challenges

8.4 Orally Disintegrating Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Eli Lilly and Company

Astrazeneca plc

Bristol–Myers Squibb

Conquer

List of Tables

Table 1. Global Orally Disintegrating Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Orally Disintegrating Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Orally Disintegrating Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Orally Disintegrating Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Orally Disintegrating Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Orally Disintegrating Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Orally Disintegrating Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Orally Disintegrating Tablets Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Orally Disintegrating Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Orally Disintegrating Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Orally Disintegrating Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Orally Disintegrating Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Orally Disintegrating Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Orally Disintegrating Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Orally Disintegrating Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Orally Disintegrating Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Orally Disintegrating Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Orally Disintegrating Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Orally Disintegrating Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Orally Disintegrating Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Orally Disintegrating Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Orally Disintegrating Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Orally Disintegrating Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Orally Disintegrating Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Orally Disintegrating Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Orally Disintegrating Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Orally Disintegrating Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Orally Disintegrating Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Orally Disintegrating Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Orally Disintegrating Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Orally Disintegrating Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Orally Disintegrating Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Orally Disintegrating Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Orally Disintegrating Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Orally Disintegrating Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Orally Disintegrating Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Orally Disintegrating Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Orally Disintegrating Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Orally Disintegrating Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Orally Disintegrating Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Orally Disintegrating Tablets Price (USD/Unit) by Type (2020-2025)

Table 59. Global Orally Disintegrating Tablets Price (USD/Unit) by Type (2026-2031)

Table 60. Global Orally Disintegrating Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Orally Disintegrating Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Orally Disintegrating Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Orally Disintegrating Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Orally Disintegrating Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Orally Disintegrating Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Orally Disintegrating Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Orally Disintegrating Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Orally Disintegrating Tablets Price (USD/Unit) by Application (2020-2025)

Table 69. Global Orally Disintegrating Tablets Price (USD/Unit) by Application (2026-2031)

Table 70. Teva Company Information

Table 71. Teva Description and Business Overview

Table 72. Teva Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Teva Orally Disintegrating Tablets Product

Table 74. Teva Recent Developments/Updates

Table 75. Merck Company Information

Table 76. Merck Description and Business Overview

Table 77. Merck Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Merck Orally Disintegrating Tablets Product

Table 79. Merck Recent Developments/Updates

Table 80. Mylan Company Information

Table 81. Mylan Description and Business Overview

Table 82. Mylan Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Mylan Orally Disintegrating Tablets Product

Table 84. Mylan Recent Developments/Updates

Table 85. Pfizer Company Information

Table 86. Pfizer Description and Business Overview

Table 87. Pfizer Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Pfizer Orally Disintegrating Tablets Product

Table 89. Pfizer Recent Developments/Updates

Table 90. Johnson and Johnson Company Information

Table 91. Johnson and Johnson Description and Business Overview

Table 92. Johnson and Johnson Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Johnson and Johnson Orally Disintegrating Tablets Product

Table 94. Johnson and Johnson Recent Developments/Updates

Table 95. GSK Company Information

Table 96. GSK Description and Business Overview

Table 97. GSK Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. GSK Orally Disintegrating Tablets Product

Table 99. GSK Recent Developments/Updates

Table 100. Otsuka Company Information

Table 101. Otsuka Description and Business Overview

Table 102. Otsuka Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Otsuka Orally Disintegrating Tablets Product

Table 104. Otsuka Recent Developments/Updates

Table 105. Eli Lilly and Company Company Information

Table 106. Eli Lilly and Company Description and Business Overview

Table 107. Eli Lilly and Company Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Eli Lilly and Company Orally Disintegrating Tablets Product

Table 109. Eli Lilly and Company Recent Developments/Updates

Table 110. AstraZeneca Company Information

Table 111. AstraZeneca Description and Business Overview

Table 112. AstraZeneca Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. AstraZeneca Orally Disintegrating Tablets Product

Table 114. AstraZeneca Recent Developments/Updates

Table 115. Bristol-Myers Squibb Company Information

Table 116. Bristol-Myers Squibb Description and Business Overview

Table 117. Bristol-Myers Squibb Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Bristol-Myers Squibb Orally Disintegrating Tablets Product

Table 119. Bristol-Myers Squibb Recent Developments/Updates

Table 120. Conquer Company Information

Table 121. Conquer Description and Business Overview

Table 122. Conquer Orally Disintegrating Tablets Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Conquer Orally Disintegrating Tablets Product

Table 124. Conquer Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Orally Disintegrating Tablets Distributors List

Table 128. Orally Disintegrating Tablets Customers List

Table 129. Orally Disintegrating Tablets Market Trends

Table 130. Orally Disintegrating Tablets Market Drivers

Table 131. Orally Disintegrating Tablets Market Challenges

Table 132. Orally Disintegrating Tablets Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Orally Disintegrating Tablets

Figure 2. Global Orally Disintegrating Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Orally Disintegrating Tablets Market Share by Type: 2024 & 2031

Figure 4. Anti-Psychotics Drug Product Picture

Figure 5. Anti-Epileptics Drug Product Picture

Figure 6. Other Product Picture

Figure 7. Global Orally Disintegrating Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Orally Disintegrating Tablets Market Share by Application: 2024 & 2031

Figure 9. CNS Diseases

Figure 10. Gastrointestinal Diseases

Figure 11. CVS Diseases

Figure 12. Other

Figure 13. Global Orally Disintegrating Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Orally Disintegrating Tablets Market Size (2020-2031) & (US$ Million)

Figure 15. Global Orally Disintegrating Tablets Sales (2020-2031) & (K Units)

Figure 16. Global Orally Disintegrating Tablets Average Price (USD/Unit) & (2020-2031)

Figure 17. Orally Disintegrating Tablets Report Years Considered

Figure 18. Orally Disintegrating Tablets Sales Share by Manufacturers in 2024

Figure 19. Global Orally Disintegrating Tablets Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Orally Disintegrating Tablets Players: Market Share by Revenue in Orally Disintegrating Tablets in 2024

Figure 21. Orally Disintegrating Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Orally Disintegrating Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 24. North America Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 28. Europe Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 29. Germany Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Orally Disintegrating Tablets Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Orally Disintegrating Tablets Revenue Market Share by Region (2020-2031)

Figure 36. China Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 47. Latin America Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Orally Disintegrating Tablets Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Orally Disintegrating Tablets Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Orally Disintegrating Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Orally Disintegrating Tablets by Type (2020-2031)

Figure 57. Global Revenue Market Share of Orally Disintegrating Tablets by Type (2020-2031)

Figure 58. Global Orally Disintegrating Tablets Price (USD/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Orally Disintegrating Tablets by Application (2020-2031)

Figure 60. Global Revenue Market Share of Orally Disintegrating Tablets by Application (2020-2031)

Figure 61. Global Orally Disintegrating Tablets Price (USD/Unit) by Application (2020-2031)

Figure 62. Orally Disintegrating Tablets Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Orally Disintegrating Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Orally Disintegrating Tablet Excipient Market Insights Forecast to 2030

Orally Dissolving Tablets ODT Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Mouth dissolving Tablets Market Insights Forecast to 2030

Global Fast disintegrating Tablets Market Insights Forecast to 2030

Global Rapid dissolving Tablets Market Insights Forecast to 2030

Global Fast dissolving Tablets Market Insights Forecast to 2030

Global Orally Disintegrating Tablets ODT Platform Market Research Report 2024

Global Orally Disintegrating Tablet Technology Market Research Report 2024

Global Orodispersible Tablets Market Insights Forecast to 2030

Global Excipients for Orally Disintegrating Tablets ODT Market Research Report 2024

Global Oral Disintegrating Strips Market Research Report 2024

Global Freeze Dried Orally Disintegrating Tablets Market Research Report 2024

Global Oral Solid Dosage Medicine Market Research Report 2025

Global Aripiprazole Orally Disintegrating Tablets ODT Market Research Report 2025

Global Oral Fast Dissolving Film OFDF Market Research Report 2024

Global Orodispersible Film Market Research Report 2025

Global Orally Fast Dissolving Films OFDFs Market Research Report 2025

Global Fast Melt Tablet Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Orally Disintegrating Tablets Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-37M1043

Global Orally Disintegrating Tablets Market Research Report 2025

FEATURED COMPANIES

Orally Disintegrating Tablets Market Size

Orally Disintegrating Tablets Market

Report Scope

Scope of Orally Disintegrating Tablets Market Report

Core Chapters

FAQ for this report

How fast is Orally Disintegrating Tablets Market growing?

What is the Orally Disintegrating Tablets Market size in 2031?

What is the Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol Myers Squibb, Conquer share in Orally Disintegrating Tablets Market?

What is the Orally Disintegrating Tablets Market share by region?

What is the Orally Disintegrating Tablets Market share by application?

Who are the main players in the Orally Disintegrating Tablets Market report?

What are the Application segmentation covered in the Orally Disintegrating Tablets Market report?

What are the Type segmentation covered in the Orally Disintegrating Tablets Market report?

FEATURED COMPANIES

Global Human Organs on Chips Market Insights and Forecast to 2028

Single User, Electronic (PDF)

Global Marketing Analytics Software Market Size Status and Forecast 2021 2027

Single User, Electronic (PDF)